UPDATE : Monday, September 7, 2020
상단여백
Korea University Medicine aims highest level of healthcare by Kim Yun-mi 2019-12-23 14:46
‘Blocking CGRP is key in migraine treatment’ by Kim Yun-mi 2019-12-19 12:15
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020 by Kim Yun-mi 2019-12-17 11:59
Regulator finds harmful substances in liquid e-cigarettes by Kim Yun-mi 2019-12-13 13:58
‘There should be no Invossa fiasco again’ by Kim Yun-mi 2019-12-11 15:03
라인
‘Lynparza raises value of precision medicine as anticancer treatment’ by Kim Yun-mi 2019-12-05 16:05
Regulator’s re-evaluation of cognitive enhancer to take time by Kim Yun-mi 2019-11-27 12:07
Roche’s flu treatment Xofluza wins approval by Kim Yun-mi 2019-11-26 16:08
Immunotherapies give hope for esophageal cancer patients by Kim Yun-mi 2019-11-26 15:37
Drugmakers obliged to conduct impurity tests and report results by Kim Yun-mi 2019-11-25 16:09
라인
Korea, Singapore to cooperate on GMP in pharmaceuticals by Kim Yun-mi 2019-11-25 14:49
‘Korea's vaccine industry needs to grow to secure self-sufficiency’ by Kim Yun-mi 2019-11-25 11:55
Regulator bans 13 nizatidine drugs over carcinogenic risk by Kim Yun-mi 2019-11-22 15:32
Regulator detects NDMA also in nizatidine drugs by Kim Yun-mi 2019-11-21 10:53
‘Japan much advanced than Korea in ALK-positive NSCLC treatment’ by Kim Yun-mi 2019-11-20 16:16
라인
Will Biogen be 1st to get FDA nod for Alzheimer’s drug? by Kim Yun-mi 2019-11-14 11:23
‘Generic drugs must indicate ingredient names on label’ by Kim Yun-mi 2019-11-13 15:51
Sanofi’s DPT vaccine in shortage in some parts of Korea by Kim Yun-mi 2019-11-11 15:27
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off by Kim Yun-mi 2019-11-07 16:10
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis by Kim Yun-mi 2019-11-06 16:00
여백
여백
여백
Back to Top